Clinical bottom line
Cholecystectomy remains the primary surgical intervention for gallbladder polyps with a significant risk of malignancy. Current evidence supports surgical removal for polyps ≥10 mm in size, symptomatic polyps, or those with suspicious morphology. However, smaller polyps (<10 mm) generally carry a low risk of neoplasia, and conservative management with imaging surveillance may be appropriate in selected patients. Age and other risk factors should inform individualized decision-making. Emerging data suggest that some surgical indications may warrant reappraisal to avoid overtreatment (Taskin et al., 2020; Kim et al., 2026; memişoğlu et al., 2021).
What the evidence shows
Taskin et al. (2020) analyzed the correlation between polyp size and histopathologic characteristics, confirming that polyps ≥10 mm are more likely to be neoplastic, including adenomas and early gallbladder carcinoma. Their findings reinforce size as a key criterion for surgery.
Kim et al. (2026) reappraised surgical indications based on age and polyp size, reporting that older patients with smaller polyps may still harbor neoplastic lesions, suggesting age-adjusted thresholds could optimize management.
memişoğlu et al. (2021) questioned the validity of current surgical indications, highlighting cases of overtreatment and advocating for more stringent criteria incorporating morphology and patient risk factors.
Carrillo et al. (2015) emphasized the importance of polyp morphology alongside size, noting that sessile or solitary polyps have higher malignant potential compared to multiple or pedunculated lesions.
Chrestiana Dewi et al. (2015) reviewed management strategies for polyps smaller than 10 mm, concluding that routine cholecystectomy is not justified unless other risk factors or symptoms are present.
Kara Yalçın Burak et al. (2024) evaluated laparoscopic cholecystectomy outcomes for gallbladder polyps, raising concerns about overtreatment and advocating for improved preoperative risk stratification.
Caveats and uncertainty
Most studies are retrospective and may be subject to selection bias.
Imaging modalities vary in sensitivity and specificity for polyp characterization, affecting clinical decision-making.
Long-term outcomes of surveillance versus surgery for small polyps remain incompletely defined.
Optimal surveillance intervals and modalities lack consensus.
Risk factors beyond size and morphology, such as patient age and comorbidities, require further validation.
How this may change practice
Clinicians should continue to recommend cholecystectomy for polyps ≥10 mm or those with suspicious features but consider individualized risk assessment incorporating age and morphology.
Smaller polyps may be managed conservatively with periodic ultrasound surveillance, reducing unnecessary surgeries.
Enhanced imaging techniques and standardized reporting can improve risk stratification.
Multidisciplinary discussion is advised for borderline cases to balance malignancy risk against surgical morbidity.
Future guidelines may incorporate refined criteria to minimize overtreatment while ensuring timely intervention for high-risk lesions.